Tandem Diabetes Care Inc at Raymond James Institutional Investors Conference Transcript
Good morning. I think we'll get started here. I'm Jayson Bedford, I cover the medtech sector here at Raymond James. Thank you for enduring a few days here. Today the 45th Annual Raymond James Institutional Investors Conference.
We're very pleased to have with us the senior management team from Tandem Diabetes. We have the company's CEO, John Sheridan, the company's CFO, Leigh Vosseller. And we really appreciate the -- that the time they're giving us. I think we'll go through a quick presentation, and I'll have some questions.
Well, welcome, everybody. Thanks, Jayson. I'm going to start off with just -- I am going to be having forward-making -- forward-looking statements. And so would you please go to our website and look at the Investor section in terms of how to deal with that.
Sorry about that. So Tandem has been around for -- about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |